Macular Degeneration & Optic Nerve Damage: What You Should Know

Understanding Vision Loss and Eye Health 

Blurry vision is not always a sign of aging; sometimes it’s a warning from the optic nerve craving attention. 

Vision plays a critical role in every facet of life. Vision impairment ranges from low vision to total blindness. Globally, more than 2.2 billion individuals have either near or distant vision impairment [1]. An estimate of more than 1 billion of these vision impairments were preventable with strategic treatment.

Age-related macular degeneration and optic nerve atrophy are among the common conditions that cause irreversible vision loss. Macular degeneration affects the macula, while optic atrophy is related to Optic Nerve Damage. 

Ask The Expert

What Is Age Related Macular Degeneration (AMD)? 

Macular degeneration affects the macula, the central part of the retina. The retina is in the back of the eye that controls central vision. Individuals suffering with Age Related Macular Degeneration primarily lose their central vision. There may or may not be complete blindness. The peripheral vision (ability to see on the sides) remains intact.

What are the Types of AMD?

• Dry (Atrophic): accounts for >90% cases of macular degeneration, tiny yellow protein deposits (drusen) are formed under the macula, deposits dry and make the macula thin, leading to gradual vision loss.
• Wet (Exudative): occurs due to abnormality of blood vessels development under the retina and macula. Leaky blood vessels (blood and fluid) builds up, it causes macula bulge. It a more severe form of AMD, leading to quick central vision loss.

What is the Stage of AMD?

• Early: Macula changes, vision isn’t affected
• Intermediate: Vision gets wavy and blurry
• Advanced: Central vision fails

What are the Symptoms of AMD?

• Compromised vision in low light
• Blurred vision
• Vision that makes a straight line appear wavy or curvy
• Dark or blank spot in the vision field

What are the Available Treatments for AMD?

• Recommendation of Nutritional Supplements: Recommended for dry AMD, E.g. Vitamin C, Vitamin E, Lutein, Zinc, Zeaxanthin, Copper
• Medications: Recommended for wet AMD, anti-VEGF injections (blocks production of abnormal blood vessels), E.g. aflibercept, bevacizumab, Ranibizumab, etc.
• Photodynamic Therapy: Recommended for AMD, a combination of light-sensitive drugs and laser, destroys abnormal blood vessels in the eye.

Understanding Optic Atrophy

Optic Nerve Atrophy is associated with optic nerve damage that carries signals from the eye to the brain. Optic atrophy can cause complete vision loss. Occurs due to progressive optic nerve damage and can be irreversible.

What are the Causes of Optic Atrophy?

• Lack of Adequate Blood Flow (Ischemia/Vascular): the most common form 
• Genetic Cause (Congenital): Leber hereditary optic neuropathy
• Extrinsic or Intrinsic Compression of Optic Nerve: Glaucoma or tumours creates intensive pressure on the optic nerves
• Other Causes: Inflammation, eye infection, trauma, retinal damage (diabetic neuropathy), exposure to toxins or nutritional deficits

What are Optic Atrophy Symptoms?

• Blurred vision
• Compromised peripheral vision
• Difficulties with colour vision

What are Common Treatments for Optic Atrophy?

• Removal of increased fluid pressure from the brain and spinal cord (hydrocephalus)
• Safety glasses, magnifier glasses, or lenses
• Glaucoma management, lowering intraocular pressure
• Nutritional support for addressing vitamin deficiencies
• Medication like corticosteroids to reduce inflammation

*NOTE: All the treatments in AMD and optic nerve atrophy intend to manage the symptoms and slow down further damage to the macula or optic nerve. However, there is no permanent cure prevailing. 

Can a Regenerative Approach AID in Macular Regeneration & Optic Nerve Regeneration?

Stem cells have set groundbreaking treatment through undertaking regenerative approaches. Stem cells aid in the differentiation of distinct cell types (e.g. macular or optic nerve). The use of mesenchymal stem cells (MSCs) has shown intensive positive outcomes. The treatment involves the repair and regeneration of macular or optic nerve cells. Researchers showed distinct mechanism including:

• Cellular Differentiation: Stem cells differentiate into specific cell type ‘macular’ or ‘optic nerve cells’
• Repair and Regeneration: Replacement of damaged cells and repair of surrounding cells
• Production of Neurotropic Factors: Promotes differentiation of nervous cells, releases glia-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), etc. These factors enable cellular recruitment, adequate proliferation and maturation.
• Immunomodulation and Anti-Inflammation: Stem cells release various anti-inflammatory molecules (IL=10, TGF-β, HGF, PEG2) and antioxidants. Reduces inflammation and reduces neurodestructive signalling
• Prevention of Cell Death: release of anti-apoptotic molecules (p53), reduces cellular apoptosis, supports the repair mechanism by stem cells

Benefits of Stem Cell Therapy

Preclinical and clinical trials have shown multiple benefits, including:

• Improved Visual acuity
• Accuracy in Colour Perception
• Improvement in Light perception
• Increased in-depth perception
• Improvement in night vision
• Accuracy in Visual Field

Studies reflected upto 83% success in Optic Nerve Regeneration with stem cell transplantation among children [2]. 

Steps Involved in Stem Cell Therapy Procedure

The stem cell administration is a multi-step process that involves:

• Patient Assessment: Involves assessing the severity of the problem, the type of eye problem, assessment of patient’s medical history, and determining the suitability of the candidate for the stem cell therapy procedure
• Stem Cell Collection and Processing: MSCs are commonly derived from bone marrow or adipose tissue from patients. Stem cells can be procured from donors, depending on the patient’s specific need. The stem cells are processed in sterile laboratory conditions
• Stem Cell Administration: Administration route depends on the patient’s specific needs. Common administration routes include intravitreal injection (injected in the vitreous cavity), subretinal injection (injected beneath the retina), periocular or retrobulbar injection (injection around the eye)
• Aftercare: Regular follow-up and adequate rehabilitation as recommended by clinicians

Quality Standards & Regulation

The use of stem cells involves strict regulation, including:

• Use of superior-quality stem cells
• Adherence to GMP and ethical standards in culturing and maintaining stem cells
• Stem cells procured from an external source must be well-maintained and regulated.

*Advancells, India, is one of the leading stem cell research laboratories in India, working on cutting-edge optical research. The laboratory is GMP certified and maintains superior quality stem cells. 

Conclusion and Future Perspective

Stem cell therapy for serious eye diseases like macular degeneration or optic atrophy is potentially laying a path towards a curative solution. Preliminary clinical trials using stem cells for AMD and optic atrophy have shown significant positive outcomes in cellular regeneration and vision improvement. Early diagnosis and treatment show better positive outcomes. Currently, large-scale clinical trial outcomes are desirable for determining long-term safety in the case of a patient’s application. 

References

1. World Health Organization. Blindness and vision impairment [Internet]. Geneva: World Health Organization; 2026 Feb 10 [cited 2026 Feb 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
2. Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy. Stem Cell Investigation. 2019 Dec 5;6:41.

FAQ’s

Q- Can Optic Nerve Damage be Reversed?

No, currently, there is no permanent cure available for optic nerve damage. The emergence of stem cell treatment has enabled the regeneration and repair of nerve cells.   

Q- Is Macular Degeneration Hereditary?

AMD is not associated with hereditary. Overall, 15-20% cases of macular degeneration have a genetic/hereditary association. 

Q- What are Early Optic Atrophy Symptoms?

Early optic atrophy includes blurry vision, decreased colour perception, reduced contrast sensitivity, narrowing of peripheral vision, etc. 

Q- Are Regenerative Treatments Safe?

Yes, preclinical and clinical trials have supported the potential safety of regenerative treatment. In future, large-scale clinical trial outcomes are desirable for ensuring long-term safety.